Eli Lilly and Company report top-line phase 3 clinical trial results for its investigational GLP-1, GIP, and glucagon agonist ...
As antibiotic resistance continues to rise worldwide, scientists are searching for new strategies to combat infections. This ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...
NMPA authorization establishes a first-in-region, mechanism-based option for Demodex blepharitis in Greater China, where ...
What it is. AXPAXLI (OTX-TKI) is an investigational, bioresorbable intravitreal hydrogel implant designed to continuously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results